Anti-amyloid immunotherapy drives APOE4 specific increases in glial reactivity, perivascular immune activation, and ARIA-like events
Akhil V. Pallerla, Chloe C. Lucido, Kai Saito, Georgia L. Nolt, José Miguel Arbonés-Mainar, Jessica L. Funnell, Diksha Satish, Lily M. Smith, Isaiah O. Stephens, Danielle S. Goulding, Steven M. MacLean, Samantha M Olmsted, Darcy Adreon, Gabriela Hernandez, Lesley R. Golden, , Lance A. Johnson
This study investigates how anti-amyloid immunotherapy affects APOE4 carriers, showing increased glial reactivity, perivascular immune activation, and ARIA-like events.
bioRxiv · Jun 29, 2026 · PreprintNeuroscience